Search for a report

UNITED STATES DRUG DISCOVERY MARKET FORECAST 2022-2028

  • You are here:
  • Home
  • Downloads
  • UNITED STATES DRUG DISCOVERY MARKET FORECAST 2022-2028

UNITED STATES DRUG DISCOVERY MARKET FORECAST 2022-2028

The United States drug discovery market is predicted to record a CAGR of 6.26% during the forecast period, 2022-2028, projecting revenue of $32933.52 million by 2028.

UNITED STATES DRUG DISCOVERY MARKET FORECAST 2022-2028

United States Drug Discovery Market by Drug Type (Small Molecule Drug, Biologic Drug) Market by Service (Chemical Services, Drug Metabolism and Pharmacokinetics Services, Biological Services, Other Pharmaceutical Services) Market by End-users (Pharmaceutical Companies, Contract Research Organizations, Research Institutes, Other End-users) Market by Technology (High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics and Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies)

Request free sample

The United States drug discovery market is predicted to record a CAGR of 6.26% during the forecast period, 2022-2028, projecting revenue of $32933.52 million by 2028.

United States Drug Discovery Market

To know more about this report, request a free sample copy

The rising use of self-administering drugs and the growing awareness about treatment and diagnosis globally drive market growth. Also, as per the World Health Organization (WHO), enhanced healthcare systems and medical treatment have enabled high survival rates from injuries and diseases in the last decade. Additionally, the prevalence of medical conditions and diseases like respiratory diseases, strokes, neurological disorders, cancer, diabetes, and cardiovascular diseases, has significantly increased. This has raised the demand for drug delivery, which influences the growth of the market studied.

Further, recent innovations and developments in drug delivery systems like transdermal patches, injectable drug delivery, and pulmonary systems offer growth opportunities. Also, the pandemic has encouraged the expansion of the drug discovery market, given the impediments witnessed like medication unavailability and the lack of healthcare infrastructure and effective treatment. in addition, the surging lifestyle-oriented diseases, technological advancements, the growing demand for specialty medicines, the rising elderly population, the increasing healthcare, and R&D expenditure contribute to market growth.

The United States drug discovery market segmentation includes the analysis of technology, service, drug type, and end-user. The technology category is further sub-segmented into pharmacogenomics and pharmacogenetics, high throughput screening, metabolomics, nanotechnology, combinatorial chemistry, biochips, spectroscopy, bioinformatics, and other technologies. Of these, high throughput screening, nanotechnology, and spectroscopy are further explained.

High throughput screening aids in automated testing of large numbers of biological or chemical compounds for a specific biological target. It is primarily used in the pharmaceutical industry, wherein many molecules’ biochemical or biological activities can be tested using automation and robotics. The automation facilitates the rapid conduct of a large number of pharmacological, genetic, or chemical tests on drug-like compounds. It also accelerates the assaying by testing many potential biological modulators.

Nanotechnology is the development of innovative research and technology at the macromolecular, molecular, and atomic levels with controlled manipulation. In addition, it offers innovative solutions, offering researchers enhanced data quality, analytical capacity, and less consumption of less sample volume in screening and storing tissue, cell, and molecular libraries. Further, it plays an essential role in improving diagnostic methods and developing better drug delivery systems and drug formulations for disease therapy.

Spectroscopy is the study of the emission and absorption of light and other radiations by matter. NMR (nuclear magnetic resonance) is a spectroscopy technique used by biochemists and chemists to investigate organic molecules’ properties. NMR can determine molecular conformation in solutions once the basic structure is known. Moreover, spectroscopy tests can provide information about the presence of chemical compounds and elements.

Some of the major companies in the United States drug discovery market include Agilent Technologies Inc, Johnson & Johnson, Pfizer Inc, Merck & Co Inc, etc.

Merck & Co Inc is a biopharmaceutical company that offers vaccines and medicines for several diseases. It majorly sells pharmaceutical products to drug wholesalers, government agencies, hospitals, and managed healthcare providers like pharmacy benefit managers and health maintenance organizations. Human health vaccine products entail preventive adult, adolescent, and pediatric vaccines. The company has its headquarters in Kenilworth, NJ.

One of its key products, KEYTRUDA®, is indicated for treating patients with metastatic on unresectable melanoma. It is also indicated for the adjuvant treatment of pediatric and adult patients with Stage III, IIC, or IIB melanoma.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2028
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Drug Type, Service, End-User, and Technology
Companies Analyzed

Pfizer Inc, Merck & Co Inc, Agilent Technologies Inc, Johnson & Johnson, Charles River Laboratories International Inc, IQVIA Holdings Inc

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY GROWTH CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON DRUG DISCOVERY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • DRUG DISCOVERY AND DEVELOPMENT PROCESS
        • DRUG DISCOVERY AND DEVELOPMENT
        • PRECLINICAL RESEARCH
        • CLINICAL RESEARCH
        • REGULATORY AUTHORITY REVIEW
        • POST MARKET SAFETY MONITORING
      • REGULATORY FRAMEWORK
    4. MARKET BY DRUG TYPE
      • SMALL MOLECULE DRUG
      • BIOLOGIC DRUG
    5. MARKET BY SERVICE
      • CHEMICAL SERVICES
      • DRUG METABOLISM AND PHARMACOKINETICS SERVICES
      • BIOLOGICAL SERVICES
      • OTHER PHARMACEUTICAL SERVICES
    6. MARKET BY END-USER
      • PHARMACEUTICAL COMPANIES
      • CONTRACT RESEARCH ORGANIZATIONS
      • RESEARCH INSTITUTES
      • OTHER END-USERS
    7. MARKET BY TECHNOLOGY
      • HIGH THROUGHPUT SCREENING
      • SPECTROSCOPY
      • COMBINATORIAL CHEMISTRY
      • BIOCHIPS
      • PHARMACOGENOMICS AND PHARMACOGENETICS
      • BIOINFORMATICS
      • METABOLOMICS
      • NANOTECHNOLOGY
      • OTHER TECHNOLOGIES
    8. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • AGILENT TECHNOLOGIES INC
        • CHARLES RIVER LABORATORIES INTERNATIONAL INC
        • IQVIA HOLDINGS INC
        • JOHNSON & JOHNSON
        • MERCK & CO INC
        • PFIZER INC

    LIST OF TABLES

    TABLE 1:  MARKET SNAPSHOT – UNITED STATES DRUG DISCOVERY

    TABLE 2:  REGULATORY FRAMEWORK

    TABLE 3:  UNITED STATES DRUG DISCOVERY MARKET, BY DRUG TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 4:  UNITED STATES DRUG DISCOVERY MARKET, BY DRUG TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 5:  UNITED STATES DRUG DISCOVERY MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 6:  UNITED STATES DRUG DISCOVERY MARKET, BY SERVICE, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 7:  UNITED STATES DRUG DISCOVERY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 8:  UNITED STATES DRUG DISCOVERY MARKET, BY END-USER, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 9:  UNITED STATES DRUG DISCOVERY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 10:  UNITED STATES DRUG DISCOVERY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 11:  LEADING PLAYERS OPERATING IN UNITED STATES DRUG DISCOVERY MARKET

    TABLE 12:  LIST OF MERGERS & ACQUISITIONS

    TABLE 13:  LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 14:  LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 15:  LIST OF BUSINESS EXPANSIONS & DIVESTITURES                        

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: DRUG DISCOVERY AND DEVELOPMENT PROCESS

    FIGURE 5: UNITED STATES DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY DRUG TYPE, IN 2021

    FIGURE 6: UNITED STATES DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2022-2028 (IN $ MILLION)

    FIGURE 7: UNITED STATES DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2022-2028 (IN $ MILLION)

    FIGURE 8: UNITED STATES DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021

    FIGURE 9: UNITED STATES DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2022-2028 (IN $ MILLION)

    FIGURE 10: UNITED STATES DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS SERVICES, 2022-2028 (IN $ MILLION)

    FIGURE 11: UNITED STATES DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2022-2028 (IN $ MILLION)

    FIGURE 12: UNITED STATES DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2022-2028 (IN $ MILLION)

    FIGURE 13: UNITED STATES DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

    FIGURE 14: UNITED STATES DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)

    FIGURE 15: UNITED STATES DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS, 2022-2028 (IN $ MILLION)

    FIGURE 16: UNITED STATES DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2022-2028 (IN $ MILLION)

    FIGURE 17: UNITED STATES DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)

    FIGURE 18: UNITED STATES DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

    FIGURE 19: UNITED STATES DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2022-2028 (IN $ MILLION)

    FIGURE 20: UNITED STATES DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2022-2028 (IN $ MILLION)

    FIGURE 21: UNITED STATES DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2022-2028 (IN $ MILLION)

    FIGURE 22: UNITED STATES DRUG DISCOVERY MARKET, BY BIOCHIPS, 2022-2028 (IN $ MILLION)

    FIGURE 23: UNITED STATES DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2022-2028 (IN $ MILLION)

    FIGURE 24: UNITED STATES DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2022-2028 (IN $ MILLION)

    FIGURE 25: UNITED STATES DRUG DISCOVERY MARKET, BY METABOLOMICS, 2022-2028 (IN $ MILLION)

    FIGURE 26: UNITED STATES DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2022-2028 (IN $ MILLION)

    FIGURE 27: UNITED STATES DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2022-2028 (IN $ MILLION)       

    1. MARKET BY DRUG TYPE
      • SMALL MOLECULE DRUG
      • BIOLOGIC DRUG
    2. MARKET BY SERVICE
      • CHEMICAL SERVICES
      • DRUG METABOLISM AND PHARMACOKINETICS SERVICES
      • BIOLOGICAL SERVICES
      • OTHER PHARMACEUTICAL SERVICES
    3. MARKET BY END-USER
      • PHARMACEUTICAL COMPANIES
      • CONTRACT RESEARCH ORGANIZATIONS
      • RESEARCH INSTITUTES
      • OTHER END-USERS
    4. MARKET BY TECHNOLOGY
      • HIGH THROUGHPUT SCREENING
      • SPECTROSCOPY
      • COMBINATORIAL CHEMISTRY
      • BIOCHIPS
      • PHARMACOGENOMICS AND PHARMACOGENETICS
      • BIOINFORMATICS
      • METABOLOMICS
      • NANOTECHNOLOGY
      • OTHER TECHNOLOGIES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now